XML 24 R9.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:      
Net income $ 897,556 $ 779,437 $ 474,505
Adjustment to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 165,156 159,609 156,758
Amortization of right-of-use assets 32,406 34,232 34,760
Stock-based compensation costs (note 10) 71,142 65,257 63,927
Loss attributable to equity method investments, net of dividends received (note 5) 10,138 8,486 11,205
(Gain) loss on equity investments (note 5) (9,922) 12,202 (14,515)
Restructuring expenses (note 18) 9,177 0 8,673
Gain on insurance recoveries (20,227) 0 0
Changes in operating assets and liabilities:      
Accounts receivable (106,511) 19,346 (129,195)
Inventories (248,833) (311,681) (21,954)
Prepaid expenses, net deferred income taxes and other current assets (138,125) (168,109) (58,154)
Accounts payable, accrued expenses and other 31,342 (247,632) 210,708
Net cash provided by operating activities 693,299 351,147 736,718
Cash flows from investing activities:      
Purchases of property, plant and equipment (119,672) (134,835) (102,712)
Patent registration costs (14,328) (21,201) (14,114)
Business acquisitions, net of cash acquired (1,012,749) (42,784) (39,067)
Purchases of investments (note 5) (32,229) (20,724) (21,788)
Proceeds from sale of investment (note 5) 3,937 6,802 0
Proceeds / (payments) on maturity of foreign currency contracts 15,196 (17,176) 19,219
Net cash used in investing activities (1,159,845) (229,918) (158,462)
Cash flows from financing activities:      
Proceeds from issuance of common stock, net 49,142 47,384 37,790
Taxes paid related to net share settlement of equity awards (30,631) (52,406) (50,209)
Payments of business combination contingent consideration (2,361) 0 (3,500)
Proceeds from borrowings, net of borrowing costs 1,070,000 288,000 90,000
Repayment of borrowings (405,000) (166,000) (612,000)
Dividends paid (258,276) (245,341) (226,713)
Net cash provided by (used in) financing activities 422,874 (128,363) (764,632)
Effect of exchange rate changes on cash (2,147) (14,434) 18,498
Net decrease in cash and cash equivalents (45,819) (21,568) (167,878)
Cash and cash equivalents at beginning of period 273,710 295,278 463,156
Cash and cash equivalents at end of period 227,891 273,710 295,278
Supplemental disclosure of cash flow information:      
Income taxes paid, net of refunds 216,866 478,120 221,359
Interest paid 47,379 22,312 23,989
Fair value of assets acquired, excluding cash 359,730 15,648 16,671
Liabilities assumed (131,765) (4,672) (1,543)
Goodwill on acquisition 786,990 38,953 24,671
Previously held equity interest 0 (4,078) 0
Deferred payments 2,542 (3,067) 3,768
Fair value of contingent consideration (2,387) 0 0
Cash paid for acquisitions $ 1,015,110 $ 42,784 $ 43,567